Matthew Angel - 03 Feb 2026 Form 3 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
CEO and President, Director, 10%+ Owner
Signature
/s/ Matthew Angel
Issuer symbol
TPST
Transactions as of
03 Feb 2026
Net transactions value
$0
Form type
3
Filing time
06 Feb 2026, 16:24:53 UTC
Previous filing
13 Jan 2023
Next filing
06 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Angel Matthew CEO and President, Director, 10%+ Owner C/O TEMPEST THERAPEUTICS, INC., 2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE /s/ Matthew Angel 06 Feb 2026 0001931356

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TPST Common Stock 8,268,495 03 Feb 2026 By Erigen LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by Erigen LLC (the "LLC"). The Reporting Person is a member of the LLC and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein.